Bio Rad实验室-A

BIO 医疗健康
$293.7 $-1.21 (-0.41%)
Market Cap: $7.92 B
Gurus Holding
11
Popularity Rank
#290
% of Shares Held
16.14%
Net Activity (Q3 2025)
+$9.1 M

Guru Ownership Trend

Guru Analysis for Bio Rad实验室-A (BIO)

Bio Rad实验室-A (BIO), a key player in the 医疗健康 sector, continues to attract institutional attention.

As of Q3 2025, a total of 11 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.28 B.

Top institutional holders include 第一老鹰投资 and 约翰·罗杰斯.

Institutional sentiment is currently Bullish. This is evidenced by a $9.1 M net inflow during the quarter.

Recent activity highlights 路易斯·摩尔·培根 who opened a new position. Conversely, 梅森·霍金斯 reduced exposure by 24.8%.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.29% Add 0.1% 2,520,319 $706.67 M Q3 2025
2.43% Reduce -1.1% 809,480 $226.97 M Q3 2025
1.53% Add 1.9% 394,414 $110.59 M Q3 2025
3.40% Reduce -24.8% 237,254 $66.52 M Q3 2025
0.01% Reduce -3.1% 133,465 $37.42 M Q3 2025
0.15% Add 41.8% 124,626 $34.94 M Q3 2025
0.21% New Buy 55,000 $15.42 M Q3 2025
0.01% Add 13.4% 31,971 $8.73 M Q3 2025
0.07% 26,750 $7.5 M Q3 2025
0.01% New Buy 10,632 $2.98 M Q3 2025
0.00% New Buy 10,195 $2.86 M Q3 2025

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q3 2025)

+$35.54 M
Total Buy Value
New Buys 3
Additions 4
-$26.44 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
4
Net Buyers
7

FAQs for Bio Rad实验室-A (BIO)

Major holders include 第一老鹰投资 ($706.67 M), 约翰·罗杰斯 ($226.97 M), 第一太平洋顾问 ($110.59 M). According to the latest reported data, 11 tracked investment managers collectively hold approximately 4.35 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $9.1 M, with 7 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited BIO. The total reported sell value was $26.44 M.

Yes, 3 managers opened new positions in BIO, and 4 increased their existing holdings. The total reported buy value was $35.54 M.